Martingale Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-4,070
Closed -$1.08M – 865
2021
Q4
$1.08M Sell
4,070
-200
-5% -$53.9K 0.01% 475
2021
Q3
$1.24M Buy
4,270
+1,670
+64% +$428K 0.02% 463
2021
Q2
$520K Sell
2,600
-114,287
-98% -$22.2M 0.01% 579
2021
Q1
$22.7M Buy
116,887
+6,170
+6% +$1.27M 0.26% 132
2020
Q4
$21.2M Buy
110,717
+86,609
+359% +$15.8M 0.24% 130
2020
Q3
$3.56M Buy
24,108
+1,002
+4% +$143K 0.04% 281
2020
Q2
$2.86M Buy
+23,106
New +$2.72M 0.03% 434

Other funds holding RGEN

Martingale Asset Management's RGEN Position: Q1 2022 in Review

Martingale Asset Management sold out of Repligen (RGEN) in Q1 2022, closing a stake of 4,070 shares — an estimated $1.08M sold.

Martingale Asset Management first reported a position in RGEN in Q2 2020 and held it in 7 quarters. The position peaked at $22.7M in Q1 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • Martingale Asset Management reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • Martingale Asset Management sold 4,070 Repligen shares in Q1 2022, an estimated $1.08M.
  • Martingale Asset Management first reported a position in Repligen in Q2 2020 and held it in 7 quarters.
  • Martingale Asset Management's Repligen position peaked at $22.7M in Q1 2021.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Martingale Asset Management's 13F filing for Q1 2022, filed 12 May 2022.